Bronchoalveolar Lavage in Occupational Lung Diseases

Carlos Robalo Cordeiro; Jessica Cemlyn Jones; Tiago Alfaro; António Jorge Ferreira

doi:10.1055/s-2007-991523

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2007; 28(5): 504-513
DOI: 10.1055/s-2007-991523

Bronchoalveolar Lavage in Occupational Lung Diseases

Carlos Robalo Cordeiro¹ , Jessica Cemlyn Jones¹ , Tiago Alfaro¹ , António Jorge Ferreira²

¹Department of Pulmonology and Allergology, Coimbra University Hospital, Coimbra, Portugal
²Institute of Hygiene and Social Medicine, Coimbra Medical School, Coimbra, Portugal

Abstract

ABSTRACT

Occupational lung diseases (OLDs) are related to the exposure and inhalation of organic, inorganic, and synthetic particles, fumes, gases, or infectious agents. From the long list of OLDs this article focuses the discussion on bronchoalveolar lavage (BAL) in parenchymal immunoinflammatory conditions, such as hypersensitivity pneumonitis (HP) and pneumoconiosis.

Several antigens may cause HP, including products of plant or animal origin, aerosolized microorganisms, and organic chemicals. BAL is used not only to assess the pathogenesis of these diseases but also to identify the typical pattern of intense lymphocytic alveolitis, usually with a CD4:CD8 ratio below normal and frequently with the presence of mast cells, plasma cells, and foamy macrophages.

Pneumoconioses are chronic interstitial lung diseases caused by the inhalation of mineral and metallic inorganic particles/dusts in an occupational setting, showing a decreasing prevalence in recent years.

BAL is a useful tool not only to express the complex pathogenic mechanisms of these entities but also in excluding other diagnoses and causes of alveolitis, and to document specific exposures, such as the identification of asbestos bodies (ABs) in asbestosis or the proliferative response of BAL lymphocytes to beryllium in chronic beryllium disease (CBD).

KEYWORDS

Bronchoalveolar lavage - occupational lung diseases - hypersensitivity pneumonitis - pneumoconiosis

Full Text

References

REFERENCES

1 Ross D J, Keynes H L, McDonald J C. SWORD'97: surveillance of work-related and occupational respiratory disease in UK. Occup Med. 1998; 48 481-485
2 Heederik D. Epidemiology of occupational respiratory diseases and risk factors. In: Annesi-Maesano I, Gulsvik A, Viegi G Respiratory Epidemiology in Europe. European Respiratory Monograph 2000 5: 429-447
3 National Institute for Occupational Safety and Health .Work-Related Lung Diseases Surveillance Report. December 2002
4 U.S. Department of Labor .Workplace Injuries and Illnesses in 2002. December 2003
5 Mapp C E. Introduction. In: Mapp CE Occupational Lung Disorders. European Respiratory Monograph 1999 4: 355
6 Pozzi E. Extrinsic allergic alveolitis (hypersensitivity pneumonitis). In: Grassi C, Brambella C, Costabel U, Stockley RA, Naeije R, Rodriguez-Roisin R Pulmonary Diseases. London; McGraw-Hill International (UK) Ltd 1999: 289-294
7 Campbell J M. Acute symptoms following work with hay. BMJ. 1932; 2 1143-1151
8 Mohr L C. Hypersensitivity pneumonitis. Curr Opin Pulm Med. 2004; 10 401-411
9 Flandes J, Heili S, Seco J G, Sabillon O, Fernández I, Ortega A. Hypersensitivity pneumonitis caused by esparto dust in a young plaster worker: a case report and review of the literature. Respiration. 2004; 71 421-423
10 Tsushima K, Fujimoto K, Yoshikawa S, Kawakami S, Koizumi T, Kubo K. Hypersensitivity pneumonitis due to Bunashimeji mushrooms in the mushroom industry. Int Arch Allergy Immunol. 2005; 137 241-248
11 Patel A M, Ryu J H, Reed C E. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol. 2001; 108 661-670
12 Fink J N, Schlueter D P, Sosman A J et al.. Clinical survey of pigeon breeders. Chest. 1972; 62 277-281
13 Wolff H, Teppo A M, Mutanen P et al.. Studies of cytokine levels in bronchoalveolar fluid lavage from patients with interstitial lung diseases. Scand J Clin Lab Invest. 2003; 63 27-36
14 Costabel U. Atlas of Bronchoalveolar Lavage. London; Chapman & Hall Medical 1998
15 The BAL Cooperative Group Steering Committee . Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis. 1990; 141 S169-S202
16 Ando M, Konishi K, Yoneda R, Tamura M. Difference in the phenotypes of bronchoalveolar lavage lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung: report of a nationwide epidemiologic study in Japan. J Allergy Clin Immunol. 1991; 87 1002-1009
17 Pardo A, Barrios R, Gaxiola M et al.. Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med. 2000; 161 1698-1704
18 Turner-Warwick M, Haslam P L. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1987; 135 26-34
19 Drent M, Jacobs J A, de Vries J et al.. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?. Eur Respir J. 1999; 13 1338-1344
20 Perez-Padilla R, Salas J, Chapela R et al.. Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis. 1993; 148 49-53
21 Robalo Cordeiro C, Freitas S, Rodrigues B et al.. Diagnosis of respiratory bronchiolitis associated lung disease. Monaldi Arch Chest Dis. 2006; 65 96-101
22 Drent M, van Nierop M AMF, Gerritsen F A, Wouters E FM, Mulder P GH. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med. 1996; 153 736-741
23 Drent M, Jacobs J A, Cobben N AM, Costabel U, Wouters E FM, Mulder P GH. Computer program supporting the diagnostic accuracy of cellular BALF analysis: a new release. Respir Med. 2001; 95 781-786
24 Drent M, Du Bois R, Poletti V. Recent advances in the diagnosis and management of nonspecific interstitial pneumonia. Curr Opin Pulm Med. 2003; 9 411-417
25 Cordeiro C R. Airway involvement in interstitial lung disease. Curr Opin Pulm Med. 2006; 12 337-341
26 Segorbe Luís A J, Abreu A F, Cordeiro C R et al.. Subclinical alveolitis in pigeon breeders. Sarcoidosis. 1989; 6(Suppl1) 61
27 Freitas M S, Pêgo A, Cordeiro C R et al.. Subclinical alveolitis in amiodarone treated patients. Eur Resp Rev. 1992; 2 224
28 Baganha M F, Abreu F, Teixeira M L et al.. Subclinical alveolitis in asbestos exposed workers. Eur Respir Rev. 1991; 1 7
29 Robalo Cordeiro A JA, Leite A CP, Lima M A et al.. Early lung involvement in silica exposed workers. Eur Respir J. 1992; 5(Suppl 15) 521
30 Cordeiro C R, Mesquita L, Teixeira L, Cardoso Oliveira L. Subclinical alveolitis in extrathoracic granulomatous disease. Sarcoidosis. 2001; 18 34-35
31 Baganha M F, Marques M AT, Leite I et al.. Subclinical alveolitis in asymptomatic individuals infected by HIV. Eur Respir J. 1994; 7(Suppl 18) 121
32 Laviolette M, Cormier Y, Loiseau A, Soler P, Leblanc P, Hance A J. Bronchoalveolar mast cells in normal farmers and subjects with farmer's lung. Am Rev Respir Dis. 1991; 144 855-860
33 Robalo Cordeiro A JA. Alveolites subclínicas: perspectiva imunológica. Rev Port Imunoalerg. 1992; 3 73-85
34 Ávila R, Lacey J. The role of Penicillium frequentans in suberosis: respiratory disease in cork workers. Clin Allergy. 1974; 4 109
35 Morais A, Winck J C, Delgado L et al.. Suberose e doença dos criadores de aves: estudo comparativo do perfil radiológico funcional e do lavado broncoalveolar. Rev Port Pneumol. 2004; 10 63-75
36 Chan-Yeung M, Dimichi-Ward H. Natural history of occupational lung disease. In: Mapp CE Occupational Lung Disorders. European Respiratory Monograph 1999 4: 446-463
37 Kayacan O, Beder S, Karnak D. Cellular profile of bronchoalveolar lavage fluid in Turkish miners. Postgrad Med J. 2003; 79 527-530
38 Rottoli P, Bargagli E, Perari M G, Cintorino M, Romeo R. Gardening in greenhouses as a risk factor for silicosis. Respiration. 2003; 70 221-223
39 Antonini J M, Taylor M D, Zimmer A T, Roberts J R. Pulmonary responses to welding fumes: role of metal constituents. J Toxicol Environ Health, Part A. 2003; 67 233-249
40 Robalo Cordeiro A JA, Baganha M F, Carmo J GA, Gaspar E, Lima M AM, Rosa M AS. Le lavage broncho-alvéolaire chez des mineurs d'uranium. Rev Fr Mal Respir. 1981; 9 241-256
41 Barbarin V, Xing Z, Delos M, Lison D, Huaux F. Pulmonary overexpression of IL-10 augments lung fibrosis and TH2 responses induced by silica particles. Am J Physiol Lung Cell Mol Physiol. 2005; 288 L841-L848
42 Robalo Cordeiro A JA, Cordeiro C R. Exposição pulmonar profissional: pneumoconioses. In: Marques Gomes MJ, Sotto-Mayor R Tratado de Pneumologia. Portugal: Permanyer 2003 2: 1407-1419
43 Bégin R. Asbestos-related diseases. In: Mapp CE Occupational Lung Disorders. European Respiratory Monograph 1999 4: 158-177
44 Teschler H, Konietzo N, Schoenfeld B, Ramin C, Schraps T, Costabel U. Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage. Am Rev Respir Dis. 1993; 147 1211-1215
45 Vathesatogkit P, Harkin T J, Addrizo-Harris D J, Bodkin M, Crane M, Rom W N. Clinical correlation of asbestos bodies in BAL fluid. Chest. 2004; 126 966-971
46 De Vuyst P, Dumortier P, Moulin E et al.. Guidelines for mineral fibre analysis in biological samples: report of the ERS Working Group. European Respiratory Society. Eur Respir J. 1998; 11 1416-1426
47 Romeo R, Scancarello G, Cassano P, Cioni F, Bacaloni A, Sartorelli P. Assessment of asbestos exposure via mineralogical analysis of bronchoalveolar lavage fluid. Med Lav. 2004; 95 17-31
48 De Vuyst P, Dumortier P, Moulin E et al.. Asbestos bodies in bronchoalveolar lavage reflect lung asbestos body concentration. Eur Respir J. 1988; 1 362-367
49 Sebastien P, Armstrong B, Monchaux G et al.. Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma. Am Rev Respir Dis. 1988; 137 75-78
50 De Vuyst P, Dumortier P, Moulin E et al.. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis. 1987; 136 1219-1224
51 Roggli V L, Coin P G, MacIntyre N R, Bell D Y. Asbestos content of bronchoalveolar lavage fluid: a comparison of light and scanning electron microscopic analysis. Acta Cytol. 1994; 38 502-510
52 Dumortier P, Thimpont J, de Maertelaer V, De Vuyst P. Trends in asbestos body count in bronchoalveolar lavage fluid over two decades. Eur Respir J. 2003; 22 519-524
53 Rom W N, Weiden M, Garcia R et al.. Acute eosinophilia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med. 2002; 166 797-800
54 Fireman E, Greif J, Schwarz Y et al.. Assessment of hazardous dust exposure by BAL and Induced Sputum. Chest. 1999; 115 1720-1728
55 Teschler H, Thompson A B, Dollenkamp R, Konietzo N, Costabel U. Relevance of asbestos bodies in sputum. Eur Respir J. 1996; 9 680-686
56 Fireman E, Lerman Y. Induced sputum in interstitial lung diseases. Curr Opin Pulm Med. 2006; 12 318-322
57 Sulotto F, Capellaro E, Chiesa A et al.. Relationship between asbestos bodies in sputum and the number of specimens. Scand J Work Environ Health. 1997; 23 48-53
58 Capellaro E, Chiesa A, Villari S et al.. Asbestos bodies in bronchoalveolar lavage fluid and sputum. Med Lav. 1997; 88 99-107
59 Fireman E, Greif J, Schwarz Y et al.. Assessment of hazardous dust exposure by BAL and induced sputum. Chest. 1999; 115 1720-1728
60 Newman L S, Mroz M M, Balkisson R, Maier L A. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005; 171 54-60
61 Sawyer R T, Parsons C E, Fontenot A P et al.. Beryllium-induced tumor necrosis factor- α production by CD4 + T cells is mediated by HLA-DP. Am J Respir Cell Mol Biol. 2004; 31 122-130
62 Rossman M D, Kern J A, Elias J A et al.. Proliferative response of bronchoalveolar lymphocytes to beryllium. Ann Intern Med. 1988; 108 687-693
63 Zhang H, Li Q, Yao R, Guo N. Experimental studies on the therapeutic effects of lung lavage with large volume of saline on silicosis. Wei Sheng Yan Jiu. 1997; 26 77-79

Carlos Robalo CordeiroM.D. Ph.D.

Department of Pulmonology and Allergology, Coimbra University Hospital

Praceta Mota Pinto, 3000 Coimbra, Portugal

Email: crobalo@mail.telepac.pt